Hemophilia therapy: the future has begun
The success story of hemophilia care first began in the 1970s, when the availability of plasma-derived concentrates of coagulation factor VIII (FVIII) and factor IX (FIX) provided efficacious treatment of bleeding in patients with hemophilia A and B. This positive scenario was consolidated in terms...
Saved in:
Published in | Haematologica (Roma) Vol. 105; no. 3; pp. 545 - 553 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Italy
Ferrata Storti Foundation
01.03.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!